GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Price-to-Free-Cash-Flow

Pacific Edge (Pacific Edge) Price-to-Free-Cash-Flow : N/A (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Price-to-Free-Cash-Flow?

As of today (2024-06-08), Pacific Edge's share price is $0.06. Pacific Edge's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02. Hence, Pacific Edge's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Pacific Edge's Price-to-Free-Cash-Flow or its related term are showing as below:

PFGTF's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.615
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Pacific Edge's Free Cash Flow per Share for the six months ended in Mar. 2024 was $-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.02.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -18.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -3.30% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 2.90% per year.

During the past 13 years, Pacific Edge's highest 3-Year average Free Cash Flow per Share Growth Rate was 31.20% per year. The lowest was -39.50% per year. And the median was -1.70% per year.


Pacific Edge Price-to-Free-Cash-Flow Historical Data

The historical data trend for Pacific Edge's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Price-to-Free-Cash-Flow Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pacific Edge Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pacific Edge's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Pacific Edge's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Edge's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Price-to-Free-Cash-Flow falls into.



Pacific Edge Price-to-Free-Cash-Flow Calculation

Pacific Edge's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.06/-0.021
=N/A

Pacific Edge's Share Price of today is $0.06.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Pacific Edge  (OTCPK:PFGTF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Pacific Edge Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge (Pacific Edge) Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

Pacific Edge (Pacific Edge) Headlines

From GuruFocus

Half Year 2024 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Trading Halt Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024